SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-20-060709
Filing Date
2020-05-13
Accepted
2020-05-13 14:43:01
Documents
1
Group Members
BERLIN-CHEMIE AGMERCURY MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2019507d1_sc13d.htm SC 13D 117233
  Complete submission text file 0001104659-20-060709.txt   118912
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Subject) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87209 | Film No.: 20872513
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SETTE SANTI, 1 FIRENZE L6 50131
Business Address VIA SETTE SANTI, 1 FIRENZE L6 50131 0039 055 56801
A. Menarini - Industrie Farmaceutiche Riunite - S.r.l. (Filed by) CIK: 0001810515 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L6 | Fiscal Year End: 1231
Type: SC 13D